DERMAPHARM HLDG INH O.N./ DE000A2GS5D8 /
2024-03-28 9:05:12 AM | Chg. -0.0600 | Volume | Bid9:59:30 PM | Ask7:45:47 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
33.7000EUR | -0.18% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 1.81 bill.EUR | 3.12% | 13.53 |
Fundamentals
FY 2022 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 2.49 EUR | -35.99% |
EPS Diluted: | - EUR | -35.99% |
Revenues per Share: | 19.03 EUR | 8.69% |
Book Value per Share: | 9.87 EUR | 6.36% |
Cash Flow per Share: | 5.36 EUR | 15.22% |
Dividend per Share: | 1.05 EUR | -51.61% |
Total | in mill. | |
Revenues: | 1,024.80 EUR | 8.69% |
Net Income: | 132.60 EUR | -36.52% |
Operating Cash Flow: | 288.50 EUR | - |
Cash and Cash Equivalents: | 151.00 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 13.53 | 15.15 |
P/S Ratio: | 1.77 | 1.98 |
P/BV ratio: | 3.41 | 3.82 |
P/CF Ratio: | 6.29 | 7.04 |
PEG: | -0.38 | -0.42 |
Earnings Yield: | 7.39% | 6.60% |
Dividend Yield: | 3.12% | 2.78% |
Market Capitalization | ||
Market Capitalization: | 1.81 bill. EUR | 2.03 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 707,923.5271 EUR | 792,370.1912 EUR |
Shares Outstanding: | 53.84 mill. |
Profitability
Gross Profit Margin: | 63.55% |
EBIT Margin: | 23.78% |
Net Profit Margin: | 12.94% |
Return on Equity: | 24.94% |
Return on Assets: | 9.39% |
Financial Strength
Liquidity I / Cash Ratio: | 69.33% |
Liquidity II / Quick Ratio: | 113.73% |
Liquidity III / Current Ratio: | 245.13% |
Debt / Equity Ratio: | 165.76% |
Dynam. Debt / Equity Ratio: | 305.44% |
Efficiency
Employees: | 2,563 |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | 399,843.93 EUR |
Net Income / Employee: | 51,736.25 EUR |
Total Assets / Employee: | 551,229.03 EUR |
* Fiscal Year End: | 2022-12-31 |
Accounting Standard: | IFRS |
Currency: | EUR |